{"altmetric_id":20155668,"selected_quotes":["Omalizumab to Mepolizumab Switch Study in Severe Eosinophilic Asthma Patients #allergies #healthnews #research"],"citation":{"altmetric_jid":"clinicaltrialsgov","authors":["GlaxoSmithKline"],"first_seen_on":"2017-05-15T01:44:15+00:00","issns":[],"journal":"ClinicalTrials.gov","last_mentioned_on":1494961333,"links":["https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02654145?term=allergies&lup_s=04\/16\/2017&lup_d=14&show_rss=Y&sel_rss=mod14&utm_source=dlvr.it&utm_medium=facebook","https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02654145?term=allergies&lup_s=04%2F16%2F2017&lup_d=14&show_rss=Y&sel_rss=mod14&utm_source=dlvr.it&utm_medium=twitter","https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02654145?term=allergies&lup_s=04%2F16%2F2017&lup_d=14&show_rss=Y&sel_rss=mod14&utm_source=dlvr.it&utm_medium=gplus"],"nct_id":"NCT02654145","pubdate":"2016-01-11T00:00:00+00:00","publisher":"ClinicalTrials.gov","title":"Omalizumab to Mepolizumab Switch Study in Severe Eosinophilic Asthma Patients","type":"clinical_trial_study_record"},"altmetric_score":{"score":1.5,"score_history":{"1y":1.5,"6m":1.5,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":1.5},"context_for_score":{"all":{"total_number_of_other_articles":8213437,"mean":6.9553152651275,"rank":3882512,"this_scored_higher_than_pct":50,"this_scored_higher_than":4148322,"rank_type":"exact","sample_size":8213437,"percentile":50},"similar_age_3m":{"total_number_of_other_articles":238646,"mean":12.375028297261,"rank":111073,"this_scored_higher_than_pct":50,"this_scored_higher_than":120273,"rank_type":"exact","sample_size":238646,"percentile":50},"this_journal":{"total_number_of_other_articles":23703,"mean":10.395725677158,"rank":10436,"this_scored_higher_than_pct":49,"this_scored_higher_than":11824,"rank_type":"exact","sample_size":23703,"percentile":49},"similar_age_this_journal_3m":{"total_number_of_other_articles":661,"mean":5.7970606060606,"rank":143,"this_scored_higher_than_pct":48,"this_scored_higher_than":319,"rank_type":"exact","sample_size":661,"percentile":48}}},"demographics":{"poster_types":{"practitioner":1},"users":{"twitter":{"cohorts":{"Practitioners (doctors, other healthcare professionals)":1}}},"geo":{"twitter":{"US":1}}},"counts":{"total":{"posts_count":3},"twitter":{"unique_users_count":1,"unique_users":["MBHolistic"],"posts_count":1},"facebook":{"unique_users_count":1,"unique_users":["74658064790"],"posts_count":1},"googleplus":{"unique_users_count":1,"unique_users":["Monterey Bay Holistic Alliance"],"posts_count":1}},"posts":{"facebook":[{"title":"Omalizumab to Mepolizumab Switch Study in Severe Eosinophilic Asthma Patients","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=10155385690829791&id=74658064790","license":"public","citation_ids":[20155668],"posted_on":"2017-05-14T23:49:06+00:00","summary":"Condition:   Asthma\nInterventions:   Drug: Mepolizumab 100mg SC;   Drug: Albuterol\/salbutamol MDIs;   Drug: Omalizumab\nSponsor:   GlaxoSmithKline\nActive, not recruiting - verified April 2017","author":{"name":"Monterey Bay Holistic Alliance","url":"https:\/\/www.facebook.com\/74658064790","facebook_wall_name":"Monterey Bay Holistic Alliance","image":"https:\/\/graph.facebook.com\/74658064790\/picture","id_on_source":"74658064790"}}],"twitter":[{"url":"http:\/\/twitter.com\/MBHolistic\/statuses\/864556611662004225","license":"gnip","citation_ids":[20155668],"posted_on":"2017-05-16T19:02:13+00:00","author":{"name":"Monterey Holistic","url":"http:\/\/www.montereybayholistic.com","image":"https:\/\/pbs.twimg.com\/profile_images\/793206537254686724\/_c1aiyQP_normal.jpg","description":"501(c)3 #health #education #exercise #healthnews #nutrition #holistic #fitness #wellness #inspirational #healing #success #quotes #yoga #chiropractic #fitness","id_on_source":"MBHolistic","tweeter_id":"28173797","geo":{"lt":37.25022,"ln":-119.75126,"country":"US"},"followers":28299},"tweet_id":"864556611662004225"}],"googleplus":[{"url":"https:\/\/plus.google.com\/+MBHolistic\/posts\/2SEqWg59rLE","license":"public","citation_ids":[20155668],"posted_on":"2017-05-16T17:02:32+00:00","summary":"Omalizumab to Mepolizumab Switch Study in Severe Eosinophilic Asthma Patients - Full Text View - ClinicalTrials.gov Try our beta test site. IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk w"}]}}